Ipsen Clinical Trials
Sponsors / Ipsen
ClinicalTrials.gov lists 320 trials for which Ipsen is named as lead sponsor. Of these, 27 are recruiting, 18 are active without new recruitment, and 222 have completed. The registry records 46 terminated or withdrawn trials for Ipsen. The most common reasons cited for termination include slow or insufficient recruitment, safety concerns. Planned participant enrollment across these trials sums to 68,987. Figures on this page are sourced from ClinicalTrials.gov and refreshed with each registry update.
320
Total Trials
27
Recruiting
18
Other Active
222
Completed
46
Terminated / Withdrawn
68,987
Total Enrollment
Termination reasons: Other39% · Recruitment37% · Safety11% · Efficacy7% · Business4% · Funding2%
Recent Terminations
- Locally Advanced Digestive System Neuroendocrine Carcinoma"low accrual"
- NCT05922579 Stopped Dec 2023Neuroendocrine Tumors"Significant and complex challenges had since been identified during recent testing phases. After their assessment, Ipsendecided to discontinue development of this motorized device in order to not burden participants."
- Moderate Upper Facial Lines"Sponsor terminated the study due to strategic considerations"
- NCT03947762 Stopped Apr 2021Pancreatic Neuroendocrine Tumor"Low enrollment"
- Advanced Cancer"Due to agreement to transfer rights for IPN01087 to an external partner, not due to safety concerns"
- Vulvodynia"lack of efficacy"
- Solid Tumor"Following an internal portfolio review, Ipsen has made the decision to terminate study D-US-60090-001. Ipsen would like to highlight that early termination was not due to any safety or tolerability issues with IPN60090"
- Salivary Gland Cancer"safety issues"
- Small Cell Lung Cancer and Breast Cancer"High number of screen failures"
- Breast Cancer"Recruitment challenges and not due to safety concerns."
Active Trials (18 total)
- NCT03647878
- NCT04106349
- NCT04526665
- NCT04821089
- NCT05361434
- NCT05377684
- NCT05627362
- NCT06016842
- NCT06089616
- NCT06258902
- NCT06305247
- NCT06383403
- NCT06447168
- NCT06730061
- NCT06833008
- NCT06850038
- NCT07185919
- NCT07191704
- NCT07213817
- NCT07213830